HI
BIIB icon

HBK Investments’s Biogen BIIB Stock Holding History

HBK Investments’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-29,311
Closed -$8.7M – 84
2019
Q4 		$8.7M Buy
+29,311
New +$8.13M 0.08% 146
2019
Q3 		– Sell
-3,697
Closed -$865K – 633
2019
Q2 		$865K Sell
3,697
-38,495
-91% -$8.89M 0.01% 452
2019
Q1 		$9.97M Buy
42,192
+17,824
+73% +$5.61M 0.1% 172
2018
Q4 		$7.33M Sell
24,368
-21,875
-47% -$6.98M 0.08% 209
2018
Q3 		$16.3M Sell
46,243
-91,930
-67% -$31.7M 0.13% 101
2018
Q2 		$40.1M Sell
138,173
-42,357
-23% -$11.9M 0.26% 40
2018
Q1 		$49.4M Buy
180,530
+151,830
+529% +$47.1M 0.34% 35
2017
Q4 		$9.14M Buy
+28,700
New +$9.21M 0.07% 166
2017
Q3 		– Sell
-66,700
Closed -$18.1M – 1016
2017
Q2 		$18.1M Buy
66,700
+36,410
+120% +$9.63M 0.11% 100
2017
Q1 		$8.28M Sell
30,290
-111,810
-79% -$31.6M 0.07% 172
2016
Q4 		$40.3M Buy
142,100
+7,284
+5% +$2.16M 0.39% 45
2016
Q3 		$42.2M Buy
134,816
+102,361
+315% +$30.3M 0.38% 43
2016
Q2 		$7.85M Buy
32,455
+6,487
+25% +$1.71M 0.06% 186
2016
Q1 		$6.76M Sell
25,968
-76,873
-75% -$20.3M 0.07% 210
2015
Q4 		$31.5M Buy
102,841
+50,309
+96% +$14.5M 0.29% 48
2015
Q3 		$15.3M Sell
52,532
-3,389
-6% -$1.12M 0.15% 95
2015
Q2 		$22.6M Buy
55,921
+18,021
+48% +$7.23M 0.23% 70
2015
Q1 		$16M Sell
37,900
-62,800
-62% -$24.8M 0.15% 77
2014
Q4 		$34.2M Buy
100,700
+44,507
+79% +$14.4M 0.42% 39
2014
Q3 		$18.6M Sell
56,193
-6,318
-10% -$2.08M 0.29% 59
2014
Q2 		$19.7M Sell
62,511
-36,089
-37% -$10.9M 0.4% 48
2014
Q1 		$30.2M Buy
98,600
+8,200
+9% +$2.6M 0.56% 28
2013
Q4 		$25.3M Buy
90,400
+52,110
+136% +$13.5M 0.49% 29
2013
Q3 		$9.22M Sell
38,290
-23,974
-39% -$5.37M 0.14% 85
2013
Q2 		$13.4M Buy
+62,264
New +$13.3M 0.21% 60

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HBK Investments's BIIB Position: Q1 2020 in Review

HBK Investments sold out of Biogen (BIIB) in Q1 2020, closing a stake of 29,311 shares — an estimated $8.7M sold.

HBK Investments first reported a position in BIIB in Q2 2013 and held it in 25 quarters. The position peaked at $49.4M in Q1 2018. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q1 2020.

  • HBK Investments reported no remaining Biogen position as of Q1 2020 after selling out during the quarter.
  • HBK Investments sold 29,311 Biogen shares in Q1 2020, an estimated $8.7M.
  • HBK Investments first reported a position in Biogen in Q2 2013 and held it in 25 quarters.
  • HBK Investments's Biogen position peaked at $49.4M in Q1 2018.
  • 1,098 funds tracked by Wall St. Rank held Biogen as of Q1 2020.

Based on HBK Investments's 13F filing for Q1 2020, filed 15 May 2020.